|
|
||||||||
Address correspondence to Dr. Dianliang Zhang, Department of General Surgery, Affiliated Hospital of Qingdao University Medical College, 16 Jiangsu Road, Qingdao 266003, Shandong Province, P. R. China; tel 86 532 8291 1324; fax 86 532 8279 0962; e-mail: phdzdl{at}yahoo.com.
This study investigated whether the single nucleotide polymorphisms (SNPs) and haplotypes of interleukin-10 (IL-10) were associated with cachexia in 223 Chinese patients with gastric cancer diagnosed by histopathological examination. Genomic DNA was extracted from peripheral blood leukocytes. The SNPs at positions –1082A/G, –819T/C, and –592A/C in the IL-10 gene promoter were analyzed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). No significant differences were found in the allele and genotype frequencies of –592A/C in patients with or without cachexia. Increased frequency of the –1082G allele was found in patients with cachexia (OR = 1.83, 95% CI, 1.00–3.33, p = 0.049). In a logistic regression analysis adjusted for body weight, carcinoma location, and stage, the –1082AG genotype was associated with an odds ratio of 1.989 (95% CI, 1.041–3.802, p = 0.037) for cachexia. The –819CC genotype was associated with an odds ratio of 3.393 (95% CI, 1.298–8.871, p = 0.013) for cachexia. Furthermore, haplotype analysis revealed that the G1082C819C592 haplotype was associated with increased risk of cachexia as compared to the A1082T819A592 haplotype (OR = 2.21; 95% CI, 1.14 – 4.30; p = 0.02). Our results suggest that genetic polymorphisms of IL-10 contribute to the susceptibility to cachexia in patients with gastric cancer in the Chinese population.
Keywords: interleukin-10, single nucleotide polymorphisms, haplotype analysis, gastric cancer, cachexia
This article has been cited by other articles:
![]() |
F. Robert, J. R. Mills, A. Agenor, D. Wang, S. DiMarco, R. Cencic, M. L. Tremblay, I. E. Gallouzi, S. Hekimi, S. S. Wing, et al. Targeting Protein Synthesis in a Myc/mTOR-Driven Model of Anorexia-Cachexia Syndrome Delays Its Onset and Prolongs Survival Cancer Res., February 1, 2012; 72(3): 747 - 756. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |